T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new cell therapy for people with hard-to-treat T-cell leukemias or lymphomas. The treatment uses the patient's own immune T cells, which are modified in the lab to recognize and attack cancer cells carrying the CD7 protein. The main goal is to check…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
Supercharged T-Cells take on tough blood cancers
Disease control Recruiting nowThis early-stage study tests a new treatment for people with T-cell leukemia or lymphoma, cancers of the blood and lymph system. Doctors take a patient's (or their donor's) immune cells, add a special receptor that helps them recognize and attack cancer cells, and then give them …
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 01, 2026 16:00 UTC